-
srdr.ahrq.gov/projects/1324/studies/175795
January 01, 2015 - Nonpharmacological Versus Pharmacological Treatments for Adult Patients With Major Depressive Disorder … Nonpharmacological Versus Pharmacological Treatments for Adult Patients With Major Depressive Disorder … Nonpharmacological Versus Pharmacological Treatments for Adult Patients With Major Depressive Disorder
-
srdr.ahrq.gov/projects/1671/studies/196094
nonopioid pharmacologic therapy, or nonpharmacologic therapy with respect to: (1) misuse, opioid use disorder … acute treatment, what is the accuracy of instruments for predicting risk of opioid misuse, opioid use disorder … treatment, what is the effectiveness of instruments for predicting risk of opioid misuse, opioid use disorder
-
srdr.ahrq.gov/projects/1671/studies/196095
January 01, 1991 - nonopioid pharmacologic therapy, or nonpharmacologic therapy with respect to: (1) misuse, opioid use disorder … acute treatment, what is the accuracy of instruments for predicting risk of opioid misuse, opioid use disorder … treatment, what is the effectiveness of instruments for predicting risk of opioid misuse, opioid use disorder
-
srdr.ahrq.gov/projects/1671/studies/196092
January 01, 2002 - nonopioid pharmacologic therapy, or nonpharmacologic therapy with respect to: (1) misuse, opioid use disorder … acute treatment, what is the accuracy of instruments for predicting risk of opioid misuse, opioid use disorder … treatment, what is the effectiveness of instruments for predicting risk of opioid misuse, opioid use disorder
-
srdr.ahrq.gov/projects/1671/studies/196084
January 01, 2007 - nonopioid pharmacologic therapy, or nonpharmacologic therapy with respect to: (1) misuse, opioid use disorder … acute treatment, what is the accuracy of instruments for predicting risk of opioid misuse, opioid use disorder … treatment, what is the effectiveness of instruments for predicting risk of opioid misuse, opioid use disorder
-
srdr.ahrq.gov/projects/1671/studies/196097
January 01, 2006 - nonopioid pharmacologic therapy, or nonpharmacologic therapy with respect to: (1) misuse, opioid use disorder … acute treatment, what is the accuracy of instruments for predicting risk of opioid misuse, opioid use disorder … treatment, what is the effectiveness of instruments for predicting risk of opioid misuse, opioid use disorder
-
srdr.ahrq.gov/projects/1671/studies/196085
January 01, 1994 - nonopioid pharmacologic therapy, or nonpharmacologic therapy with respect to: (1) misuse, opioid use disorder … acute treatment, what is the accuracy of instruments for predicting risk of opioid misuse, opioid use disorder … treatment, what is the effectiveness of instruments for predicting risk of opioid misuse, opioid use disorder
-
srdr.ahrq.gov/projects/1671/studies/196087
January 01, 2017 - nonopioid pharmacologic therapy, or nonpharmacologic therapy with respect to: (1) misuse, opioid use disorder … acute treatment, what is the accuracy of instruments for predicting risk of opioid misuse, opioid use disorder … treatment, what is the effectiveness of instruments for predicting risk of opioid misuse, opioid use disorder
-
srdr.ahrq.gov/projects/1671/studies/196086
January 01, 1998 - nonopioid pharmacologic therapy, or nonpharmacologic therapy with respect to: (1) misuse, opioid use disorder … acute treatment, what is the accuracy of instruments for predicting risk of opioid misuse, opioid use disorder … treatment, what is the effectiveness of instruments for predicting risk of opioid misuse, opioid use disorder
-
srdr.ahrq.gov/projects/1165/studies/186940
January 01, 2017 - psychotherapy versus a brief psychosocial intervention in adolescents with unipolar major depressive disorder … psychotherapy versus a brief psychosocial intervention in adolescents with unipolar major depressive disorder
-
srdr.ahrq.gov/projects/1565/studies/189298
January 01, 2014 - Longitudinal assessment of sleep disordered breathing in Vietnam veterans with post-traumatic stress disorder … Longitudinal assessment of sleep disordered breathing in Vietnam veterans with post-traumatic stress disorder … Exclusion criteria
h/o psych disorder
-
srdr.ahrq.gov/projects/1671/studies/196402
January 01, 2016 - Reset
Cancel
Study Preview
Study Title and Description
Network meta-analysis of migraine disorder … Information
Comments ( 0 ) |
Post/View
Title Data
Title
Network meta-analysis of migraine disorder
-
srdr.ahrq.gov/projects/1671/studies/196136
January 01, 2013 - Randomized clinical trial of intravenous valproate (orifil) and dexamethasone in patients with migraine disorder … Randomized clinical trial of intravenous valproate (orifil) and dexamethasone in patients with migraine disorder
-
srdr.ahrq.gov/projects/1324
January 01, 2021 - Morgans A., Carlson-Bremer D., Andrews J.
2016
Management and Outcomes of Binge-Eating Disorder … Genetic Testing for Developmental Disabilities, Intellectual Disability, and Autism Spectrum Disorder … Nonpharmacological Versus Pharmacological Treatments for Adult Patients With Major Depressive Disorder … McBroom AJ1, Lallinger KR1, Sanders-Schmidler GD1.
2017
Attention Deficit Hyperactivity Disorder … 2018
Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder
-
srdr.ahrq.gov/projects/1634/studies/193577
January 01, 2019 - chemotherapy/ Percentages of relapse and refractory AML.
23/39 had antecedent hematological disorder … Myelofibrosis and Polycythemia Rubra Vera.
23/39 had antecedent hematological disorder
-
srdr.ahrq.gov/projects/1165/studies/186898
January 01, 2012 - benefits and harms vary by subpopulation (e.g., patient characteristics, parent/caregiver characteristics, disorder
-
srdr.ahrq.gov/projects/published
December 13, 2021 - nonpharmacological and pharmacological treatments for children and adolescent a confirmed diagnosis of a depressive disorder … (DD)—major depressive disorder (MDD), persistent depressive disorder (PDD, previously termed dysthymia
-
srdr.ahrq.gov/projects/1165/studies/186946
January 01, 2009 - benefits and harms vary by subpopulation (e.g., patient characteristics, parent/caregiver characteristics, disorder
-
srdr.ahrq.gov/projects/1165/studies/186919
January 01, 2004 - benefits and harms vary by subpopulation (e.g., patient characteristics, parent/caregiver characteristics, disorder
-
srdr.ahrq.gov/projects/1596
November 22, 2019 - We included trials of Food and Drug Administration (FDA)-approved pharmacotherapies for opioid use disorder … In treatment-seeking populations with opioid use disorder, naltrexone (12 trials; relative risk [RR] … Evidence was lacking on effectiveness of treatments for opioid use disorder related to prescription drug … In treatment-seeking populations with opioid use disorder, naltrexone (12 trials; relative risk [RR] … What are the harms of naloxone in persons with opioid use disorder or misuse?